Additionally, Cyr61 (CCN1), which promotes breast tumor angiogenesis [62, 63], was down-regulated in the combinational treatment group compared to both untreated controls (Fig 4A) and vaccine alone (Fig 4B). The gene discussed is CCN1; the disease is breast neoplasm.